Clinical trial
Amifostine in Treating Patients With Advanced Myelodysplastic Syndrome
NCT00003123 · Providence Hospital, Other · Unknown status
Key facts
| NCT number | NCT00003123 |
|---|---|
| Title | Amifostine in Treating Patients With Advanced Myelodysplastic Syndrome |
| Official title | A Phase II Trial of Ethyol (Amifostine) in Adult Patients With Advanced Myelodysplastic Syndromes |
| Lead sponsor | Providence Hospital, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Myelodysplastic Syndromes |
| Intervention type | Drug |
| Interventions | amifostine trihydrate |
| Enrollment | 36 |
| Start date | Aug 1, 1997 |
| First posted | Aug 12, 2004 |
| Last update posted | Nov 6, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: